BRAF inhibitors improved erythroid differentiation from Diamond-Blackfan anemia patient-derived cells in vitro and alleviated anemia in the Rpl11 haploinsufficiency mouse model in vivo. Here, RPL11 is linked to Diamond-Blackfan anemia.